OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma
Dandan Zhang, Wen-Er Wang, Yu‐Shui Ma, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 5063-5075
Open Access | Times Cited: 5
Dandan Zhang, Wen-Er Wang, Yu‐Shui Ma, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 5063-5075
Open Access | Times Cited: 5
Showing 5 citing articles:
Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021
Chunyan Zhang, Caifang Sun, Yabin Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11389-11389
Open Access | Times Cited: 30
Chunyan Zhang, Caifang Sun, Yabin Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11389-11389
Open Access | Times Cited: 30
Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma
Sha Li, Pei Xue, Xun Diao, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 133-146
Open Access | Times Cited: 10
Sha Li, Pei Xue, Xun Diao, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 133-146
Open Access | Times Cited: 10
Integrated Analysis of DNA Repair Genes Identifies SLC6A1 as a New Marker for the Clinical Outcome of Patients with Colorectal Cancer
Qianqian Wang, Wei Yang, Liping Luo, et al.
Disease Markers (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 6
Qianqian Wang, Wei Yang, Liping Luo, et al.
Disease Markers (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 6
Transcription factor <i>ASCL1</i> targets <i>SLC6A13</i> to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling
Hongyan Zhang, Ruiqing Zong, Huiqi Wu, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 6, pp. 1606-1619
Open Access
Hongyan Zhang, Ruiqing Zong, Huiqi Wu, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 6, pp. 1606-1619
Open Access
Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma
Yinghui Zhu, Dezhi Shan, Lianyi Guo, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 1919-1931
Open Access | Times Cited: 3
Yinghui Zhu, Dezhi Shan, Lianyi Guo, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 1919-1931
Open Access | Times Cited: 3
